The Waterside Conference

  • Sponsor:

  • Exhibits:
  • Media Partners:


  • John M. Baust, PhD

    President, Founder, and Lead Scientist

    CPSI Biotech

    Next-Generation Strategies for Enhanced Cryopreservation Outcome

  • Serge Monpoeho, PhD

    Sr. Director QC & Chief Virologist

    Regeneron Pharmaceuticals, Inc.

    Atypical False Positive Observed During In Vitro Virus Assay for MAb Adventitious Virus Screening

  • Simon Joubert, PhD

    Team Leader, Cell Line Development, Life Sciences - Human Health Therapeutics Research Center

    National Research Council Canada (NRC)

    High-Throughput Screening of High-Producing CHO Cell Lines for Biomanufacturing of Biologics

  • Janike Ehret

    Scientist – Advanced Cell Culture Technologies, Life Science, Upstream R&D

    Merck KGaA

    Innovative Molecules to Simplify Fed-Batch Processes and Ensure Batch-to-Batch Consistency

  • Xiaolin Zhang, PhD

    Senior Scientist

    Merck & Co., Inc.

    Feeding TCA Cycle Intermediates Improves Lactate Consumption and Antibody Production in CHO Cell Cultures

  • Glenn A. Harris, PhD

    Director - Integrated Life Sciences Platforms

    908 Devices Inc.

    Analysis of Cell Media Degradation and Variations With a New At-Line Analyzer

  • Susan Burke, PhD

    Director Process Development, Materials Science

    Amgen Inc.

    Application of Data Analytics to Better Understand and Control Raw Material Variation

  • Harika Vemula, PhD

    Senior Scientist, Upstream R&D

    Merck KGaA

    Cell Culture Media Characterization as a Quality by Design (QbD) Tool to Assess Critical Raw Materials

  • Elizabeth C. Dodson

    Senior Manager, R&D

    Thermo Fisher Scientific

    Analytical Insights from Raw Material Testing of Cell Culture Media Components

  • Christopher Korch, PhD

    Assistant Clinical Professor, Medicine-Medical Oncology

    University of Colorado School of Medicine

    Imposter Cell Lines – A Continuing Threat to the Validity of Biomedical Research

  • Jeffrey Ly

    Associate Principal Scientist

    Merck & Co., Inc.

    Investigating Atypical Cell Culture Performance and Charge Variant Profile of a Monoclonal Antibody from a Large-Scale Mammalian Cell Culture Process

  • Charles E. Ducker, PhD

    Principal Chemist/Group Leader, Extractables and Leachables

    Eurofins Lancaster Laboratories, Inc.

    Best Practices for Planning and Conducting Extractable and Leachable Studies

  • Jamie Almeida

    Research Biologist, Biochemical Science Division, Bioassay Methods Group

    National Institute of Standards & Technology (NIST)

    Development of an Allelic Ladder for Mouse Cell Line Authentication

  • Li Zhang

    Process Development Senior Scientist

    Amgen Inc.

    Use of Stable Pools for Drug Substance Production to Support Non-Clinical Studies to Accelerate the Timeline – A Case Study

  • Balasubramanian Ramanathan, PhD

    Senior Scientist, Material Sciences, Large Molecule Value Stream, Biotherapeutics Discovery, Product Development & Supply

    Janssen Pharmaceuticals, Inc.

    Industry-Wide Benchmarking on Standardization of Trace Elements in Cell Culture Media

  • Fang Tian, PhD

    Lead Scientist, Cell Biology Group Leader, ATCC Cell Systems

    American Type Culture Collection (ATCC)

    Precision Genome Engineering of Mammalian Host Cell Lines for Enhanced Viral Production

  • Frederic Girard, PhD

    Managing Director

    Eurofins Spinnovation Analytical

    Complex Raw Material and Spent Cell Media Analyses to Support Bioprocess Development and Troubleshooting Activities

  • Chris Grinnell

    Associate Scientist III, Materials Science


    Elemental Metal Variance in Cell Culture Raw Materials: Analytical Method Design and Application

  • Sheldon Mink, PhD

    Associate Director QC Virology

    Regeneron Pharmaceuticals, Inc.

    Background NGS Data for Sample Matrix and Reference Control Standards Using Nanopore Sequencing

  • Kathryn Aron, PhD

    Group Leader, Upstream Process Development

    Bristol-Myers Squibb Company

    Implementation of an Integrated Approach for Fingerprinting Cell Culture Media

  • Matthias Brunner, PhD

    Senior Scientist

    Boehringer Ingelheim GmbH

    From Chemically to Functionally Defined: A Development Strategy to Reduce Raw Material Introduced Process Variability in Cell Culture Media

  • Sally Kline, PhD

    Head of Materials Science

    Genentech, a Member of the Roche Group

    New Approaches to Advancing a Raw Material Variability Strategy

  • Xiaoxi Wei, PhD

    Founder & CEO

    X-Therma Inc.

    A Nature Inspired DMSO-, Protein-, and Serum-Free Chemically-Defined Biopreservation Solution, the New Horizon of Precision in Cell Manufacturing and Processing

  • S. Steve Zhou, PhD

    Director, Virology and Toxicology

    MicroBioTest, div. of Microbac Laboratories, Inc.

    Surface Decontamination: Removal or Inactivation? Spray, Wipe, or Vapor?

  • Aaron C. Mack

    Senior Engineer, Materials Science


    Impact of Raw Material Variability on Cell and Gene Therapy Modalities

  • Pauline Smidt

    Principal Scientist

    Just Biotherapeutics, Inc.

    Utilizing High-Throughput Stable Transfections to Eliminate Transient Transfections for Sequence Variant Analysis

  • Allen L. Burgenson

    Global Subject Matter Expert – Testing Solutions

    Lonza Walkersville, Inc.

    Beyond LAL: rFC and MAT

  • Keith Peden, PhD

    Supervisory Research Microbiologist


    Facilitating the Introduction of New Vaccines: Addressing DNA Oncogenicity Concerns with Novel Cell Substrates

  • CHO Cell Culture Process Optimization at Low Glucose Concentrations for mAB Production

  • Phillip W. Berman, PhD

    Distinguished Research Professor, Department of Biomolecular Engineering

    University of California, Santa Cruz

    Gene Editing to Improve Upstream and Downstream Production of HIV Vaccines

  • Michael Brewer

    Director, Pharmaceutical Analytics, Life Technologies Brand; Applied Biosystems Products

    Thermo Fisher Scientific

    Update on Validation Considerations for Rapid Mycoplasma Detection Using qPCR: Regulatory Queries and Responses

  • Kelvin G.M. Brockbank, PhD


    Tissue Testing Technologies LLC

    Ice-Free Cryopreservation of Tissues and Nanowarming Employing Fe Nanoparticles and Inductive Heating

  • Jessica Maier

    Senior Scientist

    Boehringer Ingelheim Corporation

    Seed Train Intensification Using Perfusion Waves

  • Haruhiko Murata, MD, PhD

    Research Biologist (PI), Division of Viral Products, Office of Vaccines Research and Review


    Tumorigenicity Characterization of Cells

  • James Lambropoulos

    Sr. Engineer I, Proteins/Cell Culture Development


    Get Off the Critical Path: Long-Term Cell Banking Strategies and Working with Fast Timelines

  • Linda Roth, PhD

    Team Leader, Cell Bank SE, R&D, Innovative Medicines, Discovery Sciences

    AstraZeneca R&D

    Industry Cell Banking Management

  • Michael Burdick, PhD

    Associate Director, Global Pathogen Safety Support

    CSL Behring

    Facility Segregation for Downstream Processing of Plasma-Derived and Recombinant Products

  • Jyoti Velayudhan, PhD

    Associate Director

    Seattle Genetics, Inc.

  • Marc G. Aucoin, PhD

    Associate Professor, Center for Bioengineering and Biotechnology, Waterloo Institute for Nanotechnology, Department of Chemical Engineering

    University of Waterloo

  • Bud Bartlett

    Director, Procurement and Sourcing

    Alkermes plc

  • Jean Qiu, PhD

    Chief Technology Officer, Founder

    Nexcelom Bioscience LLC

  • Donna M. Altamuro

    Associate Director, Biobanking Logistics & Customer Support

    Coriell Institute for Medical Research

  • John Smith, PhD

    Principal Scientist

    Eurofins Lancaster Laboratories, Inc.

  • John Bushey

    Research Associate III

    Seattle Genetics, Inc.

  • Anissa Cheung

    Regulatory Coordinator. Division of Viral Products, OVRR


    Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications

  • Miguel Sena Esteves, PhD

    Associate Professor, Department of Neurology, Horae Gene Therapy Center

    University of Massachusetts Medical School